7 reports

  • PRESENTS CERENIS THERAPEUTICS' DYSLIPIDEMIA PORTFOLIO.
  • CERENIS THERAPEUTICS' DYSLIPIDEMIA PORTFOLIO ASSESSMENT, 2015

THE STRATEGY INCLUDES EXPANSION INTO NEGLECTED INFECTIOUS DISEASE AREAS IN THE DEVELOPING WORLD, SUCH AS MALARIA AND TUBERCULOSIS, AS WELL AS SPURRING GROWTH INTO BIOLOGICS VIA THE PRODUCTION OF BIOSIMILARS.

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

Additional assays could be developed for the platform, including tuberculosis.

  • Cholesterol
  • Point Of Care Testing
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS

THE STRATEGY INCLUDES EXPANSION INTO NEGLECTED INFECTIOUS DISEASE AREAS IN THE DEVELOPING WORLD, SUCH AS MALARIA AND TUBERCULOSIS, AS WELL AS SPURRING GROWTH INTO BIOLOGICS VIA THE PRODUCTION OF BIOSIMILARS.

  • Cholesterol
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

The period saw the launch of the Genedrive®tuberculosis (TB) and associated antibiotic resistance test in India.

  • Cholesterol
  • Clinical Trial
  • Infectious Disease
  • United States
  • GlobalData's company

The respiratory monitoring devices market is growing due to the rising incidence of chronic obstructive pulmonary diseases (COPD), asthma, and tuberculosis, coupled with technological advancements and growing awareness among people.

  • Cardiac Monitoring
  • Cholesterol
  • World
  • Market Size
  • Medtronic, Inc.

The patent contains substituted ##-qinolinemethanols and pharmaceutical compositions thereof and methods of using the same for treating of malaria, tuberculosis, and other infectious diseases.

  • Analgesic
  • Cholesterol
  • Obesity
  • Research And Development
  • Jenrin Discovery, Inc.

Non-Alcoholic Steatohepatitis - Pipeline Review, H## 2016 GMDHC##IDB / Pub July 2016 Phase I - Trial Details Phase II - Trial Details single intracutaneous injection of ##. ##ml emulsion (##mg/ ml Mycobacterium tuberculosis in IFA) into the base of the base of the tail on day ##.

  • Cholesterol
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative